Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

about

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.

P2860

Q45874985-8C7EE6BF-DE63-4BD0-B55D-3B1A9DB0F676 Q55422121-DE8FCBEC-E988-4F7E-AD56-F6094E0470D9

P2860

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

Item

http://www.wikidata.org/entity/Q50070105

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@en

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@nl

type

Item

label

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@en

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@nl

prefLabel

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@en

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@nl

P1476

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

@en

P2093

Anqi Wang

http://www.w3.org/2001/XMLSchema#string

Mingxing Li

http://www.w3.org/2001/XMLSchema#string

Peng Li

http://www.w3.org/2001/XMLSchema#string

Shengpeng Wang

http://www.w3.org/2001/XMLSchema#string

Xu Wu

http://www.w3.org/2001/XMLSchema#string

Yangyang Zhou

http://www.w3.org/2001/XMLSchema#string

Yitao Wang

http://www.w3.org/2001/XMLSchema#string

P2860

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

The receptor for the cytotoxic ligand TRAIL

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

Identification and characterization of a new member of the TNF family that induces apoptosis

X-linked IAP is a direct inhibitor of cell-death proteases

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

An endotoxin-induced serum factor that causes necrosis of tumors

P304

13879-13904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7NR04959E

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28914952

http://www.w3.org/2001/XMLSchema#string

P921

nanocarrier

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

about

P2860

P2860

Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921